Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma

NCT00179881 is registered in ClinicalTrials.gov with Ann & Robert H Lurie Children's Hospital of Chicago as lead sponsor.

NCT NCT00179881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00179881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Lead sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Phase
Phase 2
Overall status
Completed
Start date
December 31, 1999
Completion date
April 30, 2007
Enrollment
47 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

brain stem neoplasms, primary, neoplasms, brain stem